Karen Berman: Difference between revisions
Updated maintenance template(s) for biography of living person & General fixes |
Commarevival (talk | contribs) Added text, ref, category |
||
| Line 15: | Line 15: | ||
Berman received a B.S. degree from the [[University of Rochester]] and a M.D. from [[Saint Louis University School of Medicine]].<ref name=":0">{{Cite web |title=Neuroscience@NIH > Faculty > Profile |url=https://dir.ninds.nih.gov/Faculty/Profile/karen-berman.html |access-date=2022-10-05 |website=dir.ninds.nih.gov}}{{PD-notice}}</ref> She completed her [[medical internship]] at [[Washington University in St. Louis]] and had residency training in psychiatry at the [[University of California, San Diego]].<ref name=":0" /> Berman also completed residency training in [[nuclear medicine]] at the [[National Institutes of Health Clinical Center]] and is board certified in both psychiatry and nuclear medicine.<ref name=":0" /> |
Berman received a B.S. degree from the [[University of Rochester]] and a M.D. from [[Saint Louis University School of Medicine]].<ref name=":0">{{Cite web |title=Neuroscience@NIH > Faculty > Profile |url=https://dir.ninds.nih.gov/Faculty/Profile/karen-berman.html |access-date=2022-10-05 |website=dir.ninds.nih.gov}}{{PD-notice}}</ref> She completed her [[medical internship]] at [[Washington University in St. Louis]] and had residency training in psychiatry at the [[University of California, San Diego]].<ref name=":0" /> Berman also completed residency training in [[nuclear medicine]] at the [[National Institutes of Health Clinical Center]] and is board certified in both psychiatry and nuclear medicine.<ref name=":0" /> |
||
She is a senior investigator and chief of the section on integrative neuroimaging, the psychosis and cognitive studies section, and the clinical and translational neuroscience branch of the [[National Institute of Mental Health]]'s (NIMH) division of intramural research.<ref name=":1">{{Cite web |date=2016-10-24 |title=Four NIH IRP Researchers Elected to National Academy of Medicine |url=https://irp.nih.gov/blog/post/2016/10/four-nih-irp-researchers-elected-to-national-academy-of-medicine |access-date=2022-10-05 |website=[[NIH Intramural Research Program]] |language=en}}{{PD-notice}}</ref> Berman's group uses functional neuroimaging to map brain activity and neurochemical mechanisms associated with normal higher cognitive function as well as dysfunction in neuropsychiatric illnesses such as schizophrenia, illnesses having genetic sources of cognitive dysfunction such as Williams syndrome, and other conditions impacting cognition such as normal aging.<ref name=":1" /> They also study the effects of gonadal steroid hormones on brain function.<ref name=":1" /> In 2016, Berman was elected to the [[National Academy of Medicine]].<ref name=":1" /> |
She is a senior investigator and chief of the section on integrative neuroimaging, the psychosis and cognitive studies section, and the clinical and translational neuroscience branch of the [[National Institute of Mental Health]]'s (NIMH) division of intramural research.<ref name=":1">{{Cite web |date=2016-10-24 |title=Four NIH IRP Researchers Elected to National Academy of Medicine |url=https://irp.nih.gov/blog/post/2016/10/four-nih-irp-researchers-elected-to-national-academy-of-medicine |access-date=2022-10-05 |website=[[NIH Intramural Research Program]] |language=en}}{{PD-notice}}</ref> Berman's group uses functional neuroimaging to map brain activity and neurochemical mechanisms associated with normal higher cognitive function as well as dysfunction in neuropsychiatric illnesses such as schizophrenia, illnesses having genetic sources of cognitive dysfunction such as Williams syndrome, and other conditions impacting cognition such as normal aging.<ref name=":1" /> They also study the effects of gonadal steroid hormones on brain function.<ref name=":1" /> In 2016, Berman was elected to the [[National Academy of Medicine]].<ref name=":1" /> In 2023, she became a Fellow of the [[American Association for the Advancement of Science]].<ref>{{Cite web |date=2023-02-07 |title=NIMH Researcher Karen Berman Elected as AAAS Fellow - National Institute of Mental Health (NIMH) |url=https://www.nimh.nih.gov/news/science-news/2023/nimh-researcher-karen-berman-elected-as-aaas-fellow |access-date=2024-01-29 |website=www.nimh.nih.gov |language=en}}</ref> |
||
== References == |
== References == |
||
| Line 38: | Line 38: | ||
[[Category:Women medical researchers]] |
[[Category:Women medical researchers]] |
||
[[Category:Physician-scientists]] |
[[Category:Physician-scientists]] |
||
[[Category:Fellows of the American Association for the Advancement of Science]] |
|||
Revision as of 16:19, 29 January 2024
 |
Karen Berman | |
|---|---|
 | |
| Born | Karen Faith Berman |
| Alma mater | University of Rochester Saint Louis University |
| Scientific career | |
| Fields | Integrative neuroimaging, psychosis, cognitive studies |
| Institutions | National Institute of Mental Health |
Karen Faith Berman is an American psychiatrist and physician-scientist who is a senior investigator and chief of the section on integrative neuroimaging, the psychosis and cognitive studies section, and the clinical and translational neuroscience branch of the National Institute of Mental Health's division of intramural research.
Leben
Berman received a B.S. degree from the University of Rochester and a M.D. from Saint Louis University School of Medicine.[1] She completed her medical internship at Washington University in St. Louis and had residency training in psychiatry at the University of California, San Diego.[1] Berman also completed residency training in nuclear medicine at the National Institutes of Health Clinical Center and is board certified in both psychiatry and nuclear medicine.[1]
She is a senior investigator and chief of the section on integrative neuroimaging, the psychosis and cognitive studies section, and the clinical and translational neuroscience branch of the National Institute of Mental Health's (NIMH) division of intramural research.[2] Berman's group uses functional neuroimaging to map brain activity and neurochemical mechanisms associated with normal higher cognitive function as well as dysfunction in neuropsychiatric illnesses such as schizophrenia, illnesses having genetic sources of cognitive dysfunction such as Williams syndrome, and other conditions impacting cognition such as normal aging.[2] They also study the effects of gonadal steroid hormones on brain function.[2] In 2016, Berman was elected to the National Academy of Medicine.[2] In 2023, she became a Fellow of the American Association for the Advancement of Science.[3]
References
- ^ a b c "Neuroscience@NIH > Faculty > Profile". dir.ninds.nih.gov. Retrieved 2022-10-05.
This article incorporates text from this source, which is in the public domain.
- ^ a b c d "Four NIH IRP Researchers Elected to National Academy of Medicine". NIH Intramural Research Program. 2016-10-24. Retrieved 2022-10-05. This article incorporates text from this source, which is in the public domain.
- ^ "NIMH Researcher Karen Berman Elected as AAAS Fellow - National Institute of Mental Health (NIMH)". www.nimh.nih.gov. 2023-02-07. Retrieved 2024-01-29.
This article incorporates public domain material from websites or documents of the National Institutes of Health.| International | |
|---|---|
| National | |
| Academics | |
- Living people
- University of Rochester alumni
- Saint Louis University alumni
- National Institutes of Health people
- Members of the National Academy of Medicine
- 21st-century American women physicians
- 21st-century American physicians
- American psychiatrists
- American women psychiatrists
- American medical researchers
- Women medical researchers
- Physician-scientists
- Fellows of the American Association for the Advancement of Science